Makes sense. I sometimes wonder how elderly patients emotionally cope with long-term regimens — beyond the medical side, do oncologists also focus on quality-of-life conversations?

Sounds like you’ve thought about scaling beyond seniors already. Would love to hear more details on how that might work—ok if I DM you?

Exactly, that balance between rare diseases and agriculture fascinates me too. Honestly, it’s easier to exchange ideas on DM instead of long threads here — want to continue there?

I see. Thank you for your explanation. If elderly patients want to use this regimen, how do they usually monitor for side effects? I think this is very important

Fascinating work, Dr. Freedland. The link between diet and cancer progression is often underestimated. From your perspective, which interventions show the strongest clinical evidence so far? I follow related studies too—happy to exchange thoughts on WhatsApp if convenient." (298 chars)

Thanks for sharing this, Kevin. CRISPR’s progress is fascinating—especially its move toward real therapies. From your view, will rare diseases, oncology, or agriculture lead first? I’m following related work too, happy to continue on WhatsApp if easier

Big congratulations! Being the first neonatologist awardee makes this even more special. I’d love to hear what motivated you to focus on mitochondria/peroxisomes in newborns

Congratulations, Dr. Chen! Incredible milestone 👏 Curious—how do you see peroxisome research impacting neonatal care in the next few years?

Such an important point. I’ve seen friends struggle with access even when they had insurance. Do you think public–private partnerships can actually bridge this gap, or does it require something bigger?

9 out of 10 is such a striking stat—it really puts the urgency in perspective. Curious, are community education programs making a difference at all?

Really concerning trend. Do you think the biggest challenge is vaccine misinformation, or more about access and policy gaps?

Love this breakdown. Do you think CA-NC should have its own diagnostic criteria moving forward, or is it better integrated into existing cardiac arrest frameworks?

Those password resets feel like a rite of passage… happens just when you finally remember the old one 😂

Such an important topic! Telehealth exploded during the pandemic, but AI feels like the next leap. Do you see it reshaping stroke care in particular?

Wow—this really shows the reality of being ready for anything. Do you find preparation like this makes the tough days feel a bit easier to handle?

Beautifully said. Sometimes I feel patience is a muscle we train in different parts of life. Would love to hear more about how you see it in your work

Love seeing the lab having fun outside of work—bet this kind of energy carries back into the research too!

Such a fantastic achievement! These fellowships are incredibly competitive—what an exciting next step for your team’s research

Feels like we’ve been waiting for this moment forever—Pynchon still knows how to keep us on edge

Beautiful Rose of Sharon! Do you find gardening gives you the same kind of patience oncology does, or is it more of a balance to it?

Sounds like Nate has made a real difference both in the field and personally—what do you think sets him apart as a leader?

Wishing you a fulfilling retirement! Any big plans now—travel, music, or maybe mentoring the next generation?

Well deserved, congratulations! Curious—what inspired you to take on this leadership challenge at this point in your career?

Great work! From a patient perspective, reducing IRRs is huge—did you notice any differences in tolerability between older vs younger NSCLC patients?

Such important work. From a patient-care perspective, do you see this regimen being tolerable for older SMM patients as well?

Fascinating work! Do you see DNA methylation profiling becoming part of routine risk stratification for Burkitt lymphoma patients in the near future?

As physicians, we see resilience every day, but motherhood seems to embody a unique kind of strength. Do you think it shapes how many women approach challenges in medicine too?

That’s fantastic! What was the biggest clinical takeaway from his plenary talk on NMIBC?

Sounds like a strong discussion. In managing the primary for bladder cancer, do you see imaging or pathology playing the bigger role in guiding decisions?

Sounds like a great learning format! Dr. Fine, in your experience, which aspect of poster walks adds the most value for trainees—expert insights or the curated synthesis?